RegenMedTX Overview

  • Founded
  • 2014
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

RegenMedTX General Information


Developer of cell therapies for chronic kidney disease. The company develops cell therapy products that are programmed in the body to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organ.

Contact Information

Ownership Status
Financing Status
Formerly Angel backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 3929 Westpoint Boulevard
  • Suite G
  • Winston-Salem, NC 27103
  • United States
+1 (336) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RegenMedTX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Mar-2016 00.000 Completed Startup
1. Angel (individual) 05-Aug-2015 00.000 00.000 Completed Startup
To view RegenMedTX’s complete valuation and funding history, request access »

RegenMedTX Executive Team (2)

Name Title Board Seat Contact Info
Timothy Bertram Ph.D Chief Executive Officer, Board Member and Managing Director
Deepak Jain Ph.D Chief Operating Officer
To view RegenMedTX’s complete executive team members history, request access »

RegenMedTX Board Members (3)

Name Representing Role Since
Kim Westmoreland Self Board Member 000 0000
Timothy Bertram Ph.D RegenMedTX Chief Executive Officer, Board Member and Managing Director 000 0000
William Hawkins III Self Chairman 000 0000
To view RegenMedTX’s complete board members history, request access »

RegenMedTX Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 06-Mar-2015 000000000000000000 000.00 Biotechnology
Tengion Secondary Transaction - Private Biotechnology
To view RegenMedTX’s complete investments and acquisitions history, request access »